Shingrix vaccine may reduce heart disease and dementia risk

Questions about this coverage

How did the left and right cover Shingrix vaccine may reduce heart disease and dementia risk?

Of the 6 outlets on this story carrying a published leaning rating, 0% are rated left, 67% are rated centre, 33% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 7. The sections above set out what each side emphasised, in its own terms.

Is Shingrix vaccine may reduce heart disease and dementia risk left or right?

Too few of the outlets on this story carry a published leaning rating to say. 6 of them do, and this site does not characterise a field under 12: at that size one newsroom filing moves the share by ten points. The percentages above are the count as it stands.

Is the coverage of Shingrix vaccine may reduce heart disease and dementia risk biased?

Shingrix vaccine may reduce heart disease and dementia risk is one event reported by 7 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.

Which outlets covered Shingrix vaccine may reduce heart disease and dementia risk?

7 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.

What is the potential cardiovascular benefit of the Shingrix vaccine?

A study suggests the Shingrix vaccine may offer a nine percent reduction in cardiovascular disease burden over seven years compared to the older Zostavax vaccine. Specific reductions included 10% for coronary heart disease, 12% for heart failure, and 7% for atrial fibrillation.

How does Shingrix potentially reduce dementia risk?

One analysis linked the Shingrix vaccine to a 24% lower risk of dementia in older adults. Researchers are exploring whether the vaccine's AS01 adjuvant may produce temporary, beneficial changes in innate immune cells and the vascular endothelium.

When was the cardiovascular benefit of Shingrix most apparent?

The apparent cardiovascular benefit of Shingrix emerged mainly in the first 3.5 years after vaccination and then weakened. This suggests the immune changes may be time-limited.